Viz.ai, a San Francisco, CA-based applied artificial intelligence (AI) healthcare company focused on time sensitive conditions, secured $21m in Series A funding.
The round was led by Kleiner Perkins, with participation from GV, formerly Google Ventures. Mamoon Hamid, General Partner at Kleiner Perkins, will join the Viz.ai board of directors.
The company will use the funding for market expansion and to extend their product portfolio beyond stroke.
Founded in 2016 by Dr. Chris Mansi and Dr. David Golan, Viz.ai has built FDA cleared computer aided triage software to detect and triage urgent stroke cases. The AI cloud-based platform analyzes brain scans for large vessel occlusions (LVOs) and sends the scan to a neurovascular specialist to facilitate early therapeutic intervention.
The company is located in San Francisco and Tel Aviv.